Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Michigan Rogel Cancer Center
Ohio State University Comprehensive Cancer Center
Incyte Corporation
M.D. Anderson Cancer Center
Ascentage Pharma Group Inc.
Barbara Ann Karmanos Cancer Institute
City of Hope Medical Center
City of Hope Medical Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
City of Hope Medical Center
OHSU Knight Cancer Institute
University of Nebraska
University of Nebraska
University of Nebraska
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Xencor, Inc.
Northwestern University
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
Barbara Ann Karmanos Cancer Institute
University Health Network, Toronto
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Canadian Cancer Trials Group
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
University of Maryland, Baltimore
Fred Hutchinson Cancer Center
University of Maryland, Baltimore
University of Maryland, Baltimore
University of Maryland, Baltimore
University of Chicago
City of Hope Medical Center
Eli Lilly and Company
Barbara Ann Karmanos Cancer Institute
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Stanford University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Wake Forest University Health Sciences
Roswell Park Cancer Institute